Literature DB >> 12733157

Common community respiratory viruses in patients with cancer: more than just "common colds".

Krystal L Hicks1, Roy F Chemaly, Dimitrios P Kontoyiannis.   

Abstract

Community respiratory viruses long have been recognized as primary respiratory pathogens among infants and young children. More recently, it has become clear that these viruses cause a considerable disease burden throughout life. The consequences of repeated infections are most evident in elderly and immunocompromised persons. Even in otherwise healthy persons, reinfections often require medical attention but generally are undiagnosed and unrecognized. These reinfections may spread from healthy persons to those at highest risk. Control requires a multifaceted approach combining vaccination, chemoprophylaxis, and aggressive early antiviral treatment of high-risk individuals, as well as education of all populations affected by these viruses. Copyright 2003 American Cancer Society.DOI 10.1002/cncr.11353

Entities:  

Mesh:

Year:  2003        PMID: 12733157     DOI: 10.1002/cncr.11353

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  19 in total

Review 1.  Trial Watch-Oncolytic viruses and cancer therapy.

Authors:  Jonathan Pol; Aitziber Buqué; Fernando Aranda; Norma Bloy; Isabelle Cremer; Alexander Eggermont; Philippe Erbs; Jitka Fucikova; Jérôme Galon; Jean-Marc Limacher; Xavier Preville; Catherine Sautès-Fridman; Radek Spisek; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2015-12-08       Impact factor: 8.110

2.  Transfer of influenza vaccine-primed costimulated autologous T cells after stem cell transplantation for multiple myeloma leads to reconstitution of influenza immunity: results of a randomized clinical trial.

Authors:  Edward A Stadtmauer; Dan T Vogl; Eline Luning Prak; Jean Boyer; Nicole A Aqui; Aaron P Rapoport; Kenyetta R McDonald; Xiaoling Hou; Heather Murphy; Rita Bhagat; Patricia A Mangan; Anne Chew; Elizabeth A Veloso; Bruce L Levine; Robert H Vonderheide; Abbas F Jawad; Carl H June; Kathleen E Sullivan
Journal:  Blood       Date:  2010-09-23       Impact factor: 22.113

Review 3.  Influenza vaccination in children being treated with chemotherapy for cancer.

Authors:  Ginette M Goossen; Leontien C M Kremer; Marianne D van de Wetering
Journal:  Cochrane Database Syst Rev       Date:  2013-08-01

4.  Influenza vaccine immunogenicity in patients with primary central nervous system malignancy.

Authors:  Roy E Strowd; Katrina Swett; Michele Harmon; Annette F Carter; Aurora Pop-Vicas; Michael Chan; Stephen B Tatter; Thomas Ellis; Maria Blevins; Kevin High; Glenn J Lesser
Journal:  Neuro Oncol       Date:  2014-04-08       Impact factor: 12.300

5.  Immunologic consequences of chemotherapy for ovarian cancer: impaired responses to the influenza vaccine.

Authors:  Christina S Chu; Jean D Boyer; Abbas Jawad; Kenyetta McDonald; Wade T Rogers; Eline T Luning Prak; Kathleen E Sullivan
Journal:  Vaccine       Date:  2013-09-13       Impact factor: 3.641

6.  Report on influenza A and B viruses: their coinfection in a Saudi leukemia patient.

Authors:  Fahad N Almajhdi; Ghazanfar Ali
Journal:  Biomed Res Int       Date:  2013-09-02       Impact factor: 3.411

Review 7.  Antiviral prophylaxis in patients with solid tumours and haematological malignancies--update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO).

Authors:  Michael Sandherr; Marcus Hentrich; Marie von Lilienfeld-Toal; Gero Massenkeil; Silke Neumann; Olaf Penack; Lena Biehl; Oliver A Cornely
Journal:  Ann Hematol       Date:  2015-07-21       Impact factor: 3.673

8.  Immunogenicity of high-dose influenza vaccination in patients with primary central nervous system malignancy.

Authors:  Roy E Strowd; Gregory Russell; Fang-Chi Hsu; Annette F Carter; Michael Chan; Stephen B Tatter; Adrian W Laxton; Martha A Alexander-Miller; Kevin High; Glenn J Lesser
Journal:  Neurooncol Pract       Date:  2018-01-06

9.  Healthcare-associated infections in pediatric cancer patients: results of a prospective surveillance study from university hospitals in Germany and Switzerland.

Authors:  Arne Simon; Roland A Ammann; Udo Bode; Gudrun Fleischhack; Hans-Martin Wenchel; Dorothee Schwamborn; Chara Gravou; Paul-Gerhardt Schlegel; Stefan Rutkowski; Claudia Dannenberg; Dieter Körholz; Hans Jürgen Laws; Michael H Kramer
Journal:  BMC Infect Dis       Date:  2008-05-23       Impact factor: 3.090

10.  Trial watch: Oncolytic viruses for cancer therapy.

Authors:  Erika Vacchelli; Alexander Eggermont; Catherine Sautès-Fridman; Jérôme Galon; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2013-04-16       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.